N

NLS Pharmaceutics Ltd
D

NLSP

3.52000
USD
0.09
(2.62%)
Market Closed
Volume
2,802
EPS
-0
Div Yield
-
P/E
-1
Market Cap
13,429,166
OverviewSignalsIdeasNews
Related Instruments
    B
    BNGO
    -0.00920
    (-3.60%)
    0.24620 USD
    E
    EVOK
    0.06000
    (1.36%)
    4.46000 USD
    S
    SLS
    0.03000
    (2.34%)
    1.31000 USD
    V
    VTVT
    1.350
    (8.46%)
    17.310 USD
    More
News

Title: Nls Pharmaceutics Ltd

Sector: Healthcare
Industry: Biotechnology
NLS Pharmaceutics Ltd is a biopharmaceutical company. It is engaged in the discovery and development of life-improving drug therapies to treat rare and complex CNS disorders. It focuses on developing therapeutics for the treatment of neurobehavioral and neurocognitive disorders. The company's tangible assets are held in the United States. Its lead products are Quilience, to treat narcolepsy and Nolazol, to treat ADHD.